NONREACTIVE PUPILS DUE TO MONOAMINE-OXIDASE INHIBITOR OVERDOSE

被引：3
|
作者：
MALLAMPALLI, R
PENTEL, PR
ANDERSON, DC
机构：
[1] UNIV MINNESOTA,HENNEPIN CTY MED CTR,SCH MED,DEPT MED,701 PK AVE,MINNEAPOLIS,MN 55415
[2] UNIV MINNESOTA,HENNEPIN CTY MED CTR,SCH MED,DEPT NEUROL,MINNEAPOLIS,MN 55415
来源：
CRITICAL CARE MEDICINE | 1987年 / 15卷 / 05期
关键词：
D O I：
10.1097/00003246-198705000-00019
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：536 / 537
页数：2
相关论文
共 50 条
  • [1] NONREACTIVE PUPILS DUE TO MONOAMINE-OXIDASE INHIBITOR (MAOI) TOXICITY
    MALAMPALLI, RK
    PENTEL, PR
    ANDERSON, DC
    VETERINARY AND HUMAN TOXICOLOGY, 1985, 27 (04) : 313 - 313
  • [2] MONOAMINE-OXIDASE INHIBITOR OVERDOSE
    LINDEN, CH
    RUMACK, BH
    STREHLKE, C
    ANNALS OF EMERGENCY MEDICINE, 1984, 13 (12) : 1137 - 1144
  • [3] PING PONG GAZE IN REVERSIBLE COMA DUE TO OVERDOSE OF MONOAMINE-OXIDASE INHIBITOR
    WATKINS, HC
    ELLIS, CJK
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (04): : 539 - 539
  • [4] Monoamine oxidase inhibitor overdose
    Thorp, M
    Toombs, D
    Harmon, B
    WESTERN JOURNAL OF MEDICINE, 1997, 166 (04): : 275 - 277
  • [5] MONOAMINE-OXIDASE INHIBITOR TOXICITY
    PFEFFERBAUM, B
    PACK, R
    VANEYS, J
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1989, 28 (06): : 954 - 955
  • [6] PROCAINE - MONOAMINE-OXIDASE INHIBITOR IN SCHIZOPHRENIA
    BUCCI, L
    DISEASES OF THE NERVOUS SYSTEM, 1973, 34 (07): : 389 - 391
  • [7] AN IODINATED, IRREVERSIBLE INHIBITOR OF MONOAMINE-OXIDASE
    WILLIAMS, CH
    BELSHAW, B
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1985, 13 (02) : 469 - 470
  • [8] FUROXANOBENZOFUROXAN, A SELECTIVE MONOAMINE-OXIDASE INHIBITOR
    BOLT, AG
    SLEIGH, MJ
    BIOCHEMICAL PHARMACOLOGY, 1974, 23 (14) : 1969 - 1977
  • [9] HYPERMETABOLISM PRECIPITATED BY A MONOAMINE-OXIDASE INHIBITOR
    FEINGLASS, NG
    ANESTHESIOLOGY, 1988, 68 (02) : 313 - 313
  • [10] THE MONOAMINE-OXIDASE INHIBITOR TYRAMINE INTERACTION
    BROWN, C
    TANIGUCHI, G
    YIP, K
    JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 29 (06): : 529 - 532
12345